Conventional medicine treats symptoms. Regenerative medicine addresses the underlying biological processes - cellular damage, inflammation, tissue degeneration - that cause those symptoms in the first place. At Regener8MD, every regenerative protocol begins with your diagnostic assessment, so treatments are targeted, not generic.
Patient's own MSCs are Dr. Capasso's preferred approach. Using your own biology means zero rejection risk, no foreign DNA entering your body, and the ability to bank your stem cells — meaning they are harvested once, expanded in our laboratory, and stored so they are always available for future protocols. Your banked cells multiply year over year, giving you a growing reserve of your own regenerative potential.
First discovered in 2010 by Professor Mari Dezawa at Tohoku University, Muse cells are a naturally occurring subpopulation of stem cells that combine the pluripotency of embryonic stem cells with the safety profile of adult cells - with no tumor risk. They represent what peer-reviewed research now calls a new era in stem cell-based therapy.
The gold standard of regenerative medicine. Regener8MD uses umbilical cord mesenchymal stem cells (MSC), Wharton's Jelly-derived cells, and Dezawa Muse Cells - the most potent, ethically sourced stem cell types available. These cells have the unique ability to migrate to sites of damage, reduce inflammation, and stimulate tissue repair at the source.
Exosomes are the communication vehicles of the cellular world - tiny membrane-bound particles that carry growth factors, proteins, and genetic instructions between cells. Exosome therapy harnesses this natural signaling system to accelerate healing, reduce systemic inflammation, and trigger tissue regeneration at a scale that stem cells alone cannot reach.
Therapeutic plasma exchange (TPE) - sometimes called "young blood therapy" - filters and partially replaces plasma to remove the pro-aging proteins, inflammatory markers, and cellular debris that accumulate in blood over time. Harvard research has shown plasma exchange can produce measurable biological rejuvenation.
Senescent cells - sometimes called "zombie cells" - are cells that have stopped functioning but refuse to die. They accumulate with age and release a toxic cocktail of inflammatory compounds that accelerate aging across the entire body. Senolytic protocols selectively clear these cells, reducing systemic inflammation and restoring healthier tissue function.
Peptides are short chains of amino acids that act as precise biological messengers - signaling specific cellular processes like tissue repair, fat burning, immune modulation, sleep regulation, and growth hormone release. Peptide therapy allows Dr. Capasso to target specific biological processes with precision that conventional pharmaceuticals cannot match.
MSC therapy targets the root biological processes behind chronic disease and accelerated aging - not the symptoms they produce.
MSCs differentiate into tissue-specific cell types, replacing damaged cells throughout the body - from joints and cartilage to organ tissue and neural pathways.
Demonstrated efficacy resetting overactivated immune systems in multiple sclerosis, lupus, rheumatoid arthritis, Crohn's disease, and other autoimmune conditions.
By reducing chronic inflammation and replenishing damaged cells, MSC therapy measurably reverses the biological processes underlying accelerated aging - not the appearance, the biology.
The primary driver of most chronic disease and aging. MSCs are among the most potent anti-inflammatory agents in medicine - targeting inflammation systemically, not locally.
Clinical trials demonstrate MSC and Muse cell therapy addressing Parkinson's disease, Alzheimer's disease, ALS, stroke recovery, and spinal cord injury through neuronal regeneration and neuroprotection.
Muse cell clinical trials have demonstrated improved ventricular function and reduced infarct size in acute myocardial infarction, with benefits sustained through 6+ months of follow-up.
MSCs migrate to damaged organ tissue - liver, kidney, lung - and differentiate into functional organ-specific cells, potentially restoring capacity that disease or aging has eroded.
Research has demonstrated stem cell therapy's ability to regenerate insulin-producing beta cells, improve metabolic efficiency, and address the cellular dysfunction behind metabolic syndrome and type 2 diabetes.
Patients consistently report increased energy, stamina, mental clarity, libido, sleep quality, strength, and balance - reflecting systemic biological improvement, not symptom suppression.
This list represents conditions where peer-reviewed research has demonstrated clinical benefit. Individual eligibility and outcomes vary. Dr. Capasso will assess your specific biology during your diagnostic consultation.
Dr. Capasso won't recommend a treatment until he's read your biomarkers. The assessment tells him what your body needs - then the regenerative protocol is built around those findings.
